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Abstract: In the search for bioactive natural products, our lab screens hydrophobic extracts 
from marine fungal strains. While hydrophilic active substances were recently identified 
from marine macro-organisms, there was a lack of reported metabolites in the marine fungi 
area. As such, we decided to develop a general procedure for screening of hydrophobic 
metabolites. The aim of this study was to compare different processes of fermentation and 
extraction, using six representative marine fungal strains, in order to define the optimized 
method for  production. The parameters studied were (a) which polar solvent to  select,  
(b) which fermentation method to choose between solid and liquid cultures, (c) which raw 
material, the mycelium or its medium, to extract and (d) which extraction process to apply. 
The  biochemical  analysis  and  biological  evaluations  of  obtained  extracts  led  to  the 
conclusion that the culture of marine fungi by agar surface fermentation followed by the 
separate extraction of the mycelium and its medium by a cryo-crushing and an enzymatic 
digestion with agarase, respectively, was the best procedure when screening for hydrophilic 
bioactive  metabolites.  During  this  development,  several  bioactivities  were  detected, 
confirming  the  potential  of  hydrophilic  crude  extracts  in  the  search  for  bioactive  
natural products. 
Keywords: marine fungi; hydrophilic metabolites; bioactivity; agar surface fermentation; 
submerged fermentation; extraction process 
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Abbreviations: ASF: agar surface fermentation; EAP: extraction by aqueous process, EOP: 
extraction  by  organic  process,  MED:  minimal  effective  dose;  SmF:  submerged 
fermentation; SSF: solid state fermentation 
 
1. Introduction 
Marine fungi are efficient producers of organic molecules with original chemical skeletons and 
various associated bioactivities [1,2]. However, a majority produce hydrophobic compounds isolated, 
through organic solvent extraction and purification [3]. Nevertheless, some results have proved that 
bioactive hydrophilic substances can be obtained from marine fungi [4–6]. In the same way, promising 
hydrophilic pharmaceutical substances have been isolated from other marine organisms [7] or from 
terrestrial micro  and macro fungi  [8].  This  fact  prompted us  to  broaden our bioactivity screening 
method to the search for hydrophilic fungal metabolites. 
According  to  the  literature,  submerged  fermentation  (SmF)  followed  by  extraction  of  the 
metabolites  from  the  filtrate  [4–6,8]  is  the  most  current  procedure,  probably  due  to  the  easy 
accessibility  of  solubilized  compounds  in  the  culture  filtrate.  However,  some  disadvantages  are 
apparent.  Firstly,  fungal  products  not  excreted  are  lost,  and  these  types  of  products  are  often 
chemically different from those excreted. Secondly, fungi are known to adapt their metabolic pathways 
according to their environment [9], so they could produce a different variety of metabolites in other 
cultural conditions, such as in solid state fermentation (SSF) like agar surface fermentation (ASF).  
The aims of the present work are: firstly, to develop a mode of production of bioactive hydrophilic 
metabolites by fungi in order to obtain large biomasses with the maximum amount and variety of 
metabolites, and, secondly, to perform an extraction process so as to retrieve the maximum quantity of 
biosynthesized metabolites, without any degradation during the process.  
To achieve these objectives, several issues need to be resolved: which polar solvent (methanol or 
water)  to  select;  which  fermentation  process  (SmF  or  ASF)  to  use;  which  kind  of  raw  material 
(mycelium or medium) to extract; which kind of extraction to apply so as to recover both intracellular 
metabolites from the mycelium and excreted metabolites trapped within agar-agar. 
The  proposed  method  will  take  into  account  the  difficulties  inherent  in  handling  hydrophilic 
substances [10] and be compatible with the constraints of a bioactivity screening, i.e., easily applicable 
to a large number of strains for routine use at the laboratory scale. 
Before starting the experiments, some choices were made regarding the objectives described above. 
We decided to work on six different marine fungal strains as a compromise between the minimum 
necessary  to  draw  a  general  conclusion  from  the  results  and  the  maximum  achievable  given  our 
analysis capacity. All were chosen from our marine fungal collection for their affiliation to various 
genera and their potential as producers of bioactive hydrophobic substances. 
Among  several  different  fermentation  methods,  SmF  and  ASF  were  selected  to  investigate  the 
bioactive metabolite production.  
Although  some  methods  have  been  described  for  the  extraction  of  hydrophilic  extracellular 
metabolites from SSF [11], none deal with the problem of the solubilization of the metabolites trapped Mar. Drugs 2011, 9                       
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in  a  gelled  solid  support  of  agar-agar.  We  decided  to  test  two  solvents,  methanol  and  water,  on 
mycelium and medium (agar-agar). 
Methanol  can  dissociate  fungal  walls  and  extract  the  metabolites  trapped  within  agar-agar. 
However, this polar solvent is not efficient for the extraction of macromolecules and could destroy 
sensitive macromolecules. Moreover, this method is restricted to solid medium.  
Water is more effective to extract hydrophilic compounds, however, a complementary method, such 
as  a  mechanical  or  enzymatic  one,  is  required.  We  evaluated  the  efficiency  of  cryo-crushing  and 
enzymatic digestion for both mycelium and medium (agar-agar). 
Once the fermentation method and the extraction process had been determined, it became important 
to choose the raw material to extract. Mycelium and medium were extracted separately and compared. 
Although it increases the number of experiments, the advantage of dealing with the mycelium and 
medium separately lies in producing less complex crude extracts enriched in the target compounds.  
In order to interpret the results, biochemical analyses and biological assays were used. We chose 
quantitative  assays  of  proteins  and  sugars  as  criteria  for  the  detection  of  hydrophilic  metabolites, 
considering that a large production of primary metabolites may be predictive of a large production of 
secondary  metabolites.  A  specific  neuroactivity  assay  on  blowfly  larvae  and  a  commonly  used 
cytotoxicity assay on KB cells were used to monitor the presence of bioactivity. 
Figure 1 shows the general protocol used in this study. All conditions were tested in triplicate. 
Figure 1. Protocols developed for the optimization of an extraction model for screening 
hydrophilic fungal metabolites. 
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2. Results and Discussion 
2.1. Choice of the extraction process: organic or aqueous process? 
Biochemical analyses (Table 1) on ASF showed that extraction by the aqueous process (EAP) was 
more efficient than by the organic process (EOP). Compared with EOP, protein yields from EAP were 
greater by a factor of about five for mycelium (14.19 mg/g dw  vs. 2.75 mg/g dw) and agar-agar 
(0.36 mg/mL vs. 0.08 mg/mL) crude extracts. Similarly, differences in sugar yields were also obtained 
between crude extracts from EAP and EOP (mycelium: 44.18 mg/g dw vs. 23.33 mg/g dw; medium: 
2.21  mg/mL  vs.  0.38  mg/mL).  Such  dissimilarities  between  the  two  extraction  processes  can  be 
explained by the lower solubility of hydrophilic compounds in methanol. 
Concerning the diversity of proteins found in these crude extracts, complex electrophoretic patterns 
were  observed  over  a  wide  range  of  molecular  weights  from  3.5  to  250  kDa  (data  not  shown). 
However,  more  bands  were  recognized  in  cryo-crushed  mycelium  and  digested  agar-agar  EAP 
extracts,  confirming  that  EAP  is  more  efficient  quantitatively  and  qualitatively  for  recovering 
macromolecules. 
According  to  Table  2,  neuroactivity  was  observed  more  frequently  in  EOP  extracts  (10  active 
extracts vs. 6 active extracts) but the intensity was higher in EAP extracts (minimal effective dose 
MED:  12.5  mg/mL  vs.  50  mg/mL).  In  the  same  culture  conditions,  EAP  was  more  efficient  at 
extracting the hydrophilic cytotoxic compounds than EOP (5 vs. 0 cytotoxic extracts). However, in all 
EAP extracts, values of IC50 were weak according to international criteria [12]. 
In  conclusion,  EAP  was  more  efficient  in  the  extraction  of  fungal  hydrophilic  metabolites,  for 
mycelium as well as for medium, regarding biochemical and biological assays. This extraction process 
was selected for our bioactivity screening model despite being more difficult to implement. Mar. Drugs 2011, 9                       
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Table 1. Protein and sugar contents of mycelium and medium crude extracts of the six studied marine fungal strains in ASF (agar surface 
fermentation)  obtained  by  EOP  (extraction  by  organic  process)  and  EAP  (extraction  by  aqueous  process)  and  in  SmF  (submerged 
fermentation) obtained by EAP. 
  EOP  EAP 
  ASF  ASF  SmF 
  mycelium  agar-agar  mycelium  agar-agar  mycelium  filtrate
a 
  protein yield 
(mg/g dw) 
sugar yield 
(mg/g dw) 
protein yield 
(mg/mL) 
sugar yield 
(mg/mL) 
protein yield 
(mg/g dw) 
sugar yield 
(mg/g dw) 
protein yield 
(mg/mL) 
sugar yield 
(mg/mL)  
protein yield 
(mg/g dw) 
sugar yield 
(mg/g dw) 
protein yield 
(mg/mL) 
sugar yield 
(mg/mL) 
Penicillium citreonigrum  0.78  14.25  0.07  0.25  10.67  34.19  0.55  2.13  9.52  35.41  0.36  2.27 
Phoma sp.  1.11  11.11  0.09  0.65  14.45  33.32  0.60  3.56  13.87  32.15  0.37  4.13 
Phoma exigua var exigua  2.48  20.23  0.05  0.31  10.50  44.25  0.22  0.85  11.19  42.63  0.19  0.77 
Scopulariopsis sp.  4.01  36.43  0.12  0.21  16.04  51.35  0.42  1.33  16.54  50.86  0.28  1.19 
Chrysosporium queenslandicum  5.70  37.66  0.08  0.45  21.03  55.28  0.15  2.43  23.17  53.77  0.13  2.25 
Pycnidiophora dispersa  2.43  20.30  0.09  0.42  12.44  46.66  0.20  2.97  11.35  45.34  0.18  2.08 
average  2.75  23.33  0.08  0.38  14.19  44.18  0.36  2.21  14.27  43.36  0.25  2.12 
aexpressed per mL of culture medium. 
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Table 2. Neuroactivity on Diptera larvae expressed by the MED (minimal effective dose) in mg/mL and cytotoxicity on KB cells expressed 
by the IC50 (inhibition concentration of 50% of cellular growth) in µg/mL of mycelium and medium crude extracts of the six studied marine 
fungal strains cultivated in ASF (agar surface fermentation) extracted by EOP (extraction by organic process) and EAP (extraction by aqueous 
process) and in SmF (submerged fermentation) extracted by EAP. 
  EOP  EAP 
  ASF  ASF  SmF 
  mycelium  agar-agar  mycelium  agar-agar  mycelium  filtrate 
  neuroactivity
MED 
mg/mL 
cytotoxicity 
IC50 
µg/mL
 
neuroactivity
MED 
mg/mL 
cytotoxicity 
IC50 
µg/mL
 
neuroactivity
MED 
mg/mL 
cytotoxicity 
IC50 
µg/mL
 
neuroactivity
MED 
mg/mL 
cytotoxicity 
IC50 
µg/mL
 
neuroactivity
MED 
mg/mL 
cytotoxicity 
IC50 
µg/mL
 
neuroactivity
MED 
mg/mL 
cytotoxicity 
IC50 
µg/mL
 
Penicillium citreonigrum  100  -  100  -  12.5  -  100  -  50  -  -  - 
Phoma sp.  50  -  -  -  25  68  100  130  50  62  100  85 
Phoma exigua var exigua  50  -  100  -  -  -  -  57  -  -  -  97 
Scopulariopsis sp.  100  -  100  -  100  -  -  44  -  -  -  48 
Chrysosporium 
queenslandicum 
100  -  100  -  100  -  -  - 
100  -  -  - 
Pycnidiophora dispersa  100  -  -  -  -  70  -  -  -  94  -  - 
inert medium      -  -      -  -      -  - 
The sign – means the absence of neuroactivity or cytotoxicity at the highest tested concentrations. 
Positive control: - neuroactivity: domoic acid; MED = 50 ng/mL; - cytotoxicity: gliotoxin; IC50 = 0.3 µg/mL. 
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2.2. Choice of the fermentation method: SmF or ASF? 
On average, the amounts of biomass produced per liter of culture medium by the six studied strains 
in  ASF  were  three-times  higher  than  those  produced  in  SmF  (Table  3).  However,  Penicillium 
citreonigrum  and  Pycnidiophora  dispersa  strains  gave  more  comparable  amounts  of  biomass  
(ASF: 50.0 and 54.2 g/L; SmF: 35.6 and 31.7 g/L, respectively). These two strains grew differently 
from the others: the mycelium developed on the surface of the liquid medium, mimicking growth in 
ASF conditions and so explaining the comparable amounts of biomass.  
Table 3. Biomass of the six studied marine fungal strains obtained by ASF (agar surface 
fermentation) and SmF (submerged fermentation).  
  Biomass
a (g dw/L)
 
  ASF  SmF 
Penicillium citreonigrum  50.0 ±  2.1  35.6 ±  1.8 
Phoma sp.  33.3 ±  1.7  7.1 ±  0.2 
Phoma exigua var exigua  53.4 ±  2.4  6.2 ±  0.3 
Scopulariopsis sp.  57.9 ±  2.6  2.0 ±  0.1 
Chrysosporium queenslandicum  5.8 ±  0.3  0.8 ±  0.3 
Pycnidiophora dispersa  54.2 ±  1.9  31.7 ±  1.5 
average  42.4  13.9 
a expressed per liter of culture medium; results represent biomass mean ±  SD (n = 3). 
EAP was chosen so that both types of fermentation could be compared. 
Both  fermentation  methods  gave  comparable  electrophoretic  patterns  (Figure  2,  e.g.,  P. 
citreonigrum extracts, mycelium: lanes 1 and 2, medium: lanes 3 and 5). 
Similar  protein  and  sugar  yields  (14.19  mg/g  dw  vs.  14.27  mg/g
  dw  and  44.18  mg/g  dw  vs. 
43.36 mg/g dw respectively) were observed on average in mycelium crude extracts from ASF and SmF 
(Table 1). However, the amount of proteins and sugars in the medium were greater in ASF than SmF, 
suggesting  that  the  destination  of  some  macromolecules  was  affected  by  the  culture  conditions 
(proteins: 0.36 mg/mL
 vs. 0.25 mg/mL and sugars: 2.21 mg/mL vs. 2.12 mg/mL). This difference is in 
agreement with previous works on secreted fungal proteins [13,14].  
As crude extracts from both fermentations were quantitatively and qualitatively comparable, the 
bioactivities were investigated. The bioactive compounds detected are synthesized by the same species 
cultivated in ASF or SmF (Table 2). However, ASF seemed more suitable to promote the production 
of neuroactive compounds than SmF: 6 active extracts vs. 4 active extracts; highest neuroactivities 
observed (e.g.,  P.  citreonigrum:  MED of 12.5 mg/mL  for mycelium  crude extracts  from  ASF  vs. 
50 mg/mL  for  mycelium  crude  extracts  from  SmF).  As  has  already  been  demonstrated  for  the 
production of enzymes, lipids or hydrophobic metabolites [14–16], neuroactive hydrophilic metabolite 
production by fungi is dependent on the fermentation used and these molecules are intracellular. 
No marked difference was observed concerning the cytotoxicity: 5 active extracts and similar IC50 
for  both  types  of  fermentation  (Table  2).  Either  fermentation  method  is  suitable  to  produce  
cytotoxic substances. 
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Figure 2. Analysis of protein components of EAP extracts from P. citreonigrum strain in 
ASF  (agar  surface  fermentation)  and  SmF  (submerged  fermentation).  SDS-PAGE 
electrophoresis  (12%  acrylamide)  and  successive  Coomassie  blue  and  silver  stainings.  
M:  molecular  weight  markers  (in  kDa),  Lanes  1:  cryo-crushed  mycelium  from  ASF,  
2: cryo-crushed mycelium from SmF, 3: digested agar-agar from ASF, 4: inert agar-agar,  
5: culture filtrate from SmF, 6: inert culture filtrate. 
 
As ASF produces greater quantities of biomass and promotes hydrophilic neuroactive metabolite 
production, this fermentation method would be preferred in a bioactivity screening context for the 
simultaneous  detection  of  neuroactive  and  cytotoxic  hydrophilic  compounds  in  extracts.  At  the 
laboratory scale, the use of ASF rather than SmF brings significant benefits: a lower risk of microbial 
contamination, lower sterility demands, no enzymatic degradation, smaller volume of water, less cost 
and energy [17]. Moreover, ASF can be used on smaller quantities of culture medium in a shorter time 
than SmF, indicating its potential for profitable cultures on a large scale. 
2.3. Choice of the raw material to extract: mycelium and/or medium? 
EAP was chosen so that both raw materials could be compared. 
We investigated both mycelium and medium extracts in order to prove the greater interest of one 
over the other. In all cases, mycelium extracts were richer in proteins and sugars compared to those of 
agar-agar (Table 1). 
Mycelium and medium extracts did not exhibit the same electrophoretic patterns (Figure 2, lanes 1 
and  2:  mycelium  from  ASF  and  SmF  respectively;  lanes  3  and  5:  medium  from  ASF  and  SmF 
respectively), even though some bands were observed in both extracts. 
Concerning the neuroactivity in ASF conditions, mycelium extracts were more active than agar-agar 
extracts:  4  vs.  2  active  extracts  and  MED  of  12.5  mg/mL  vs.  100  mg/mL  (e.g.,  P.  citreonigrum,  
Table 2). Similar results were observed in SmF extracts. Neuroactive hydrophilic substances did not 
seem to be excreted by fungi into the medium or only in small quantities. These results demonstrate Mar. Drugs 2011, 9                       
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the  advantage  of  working  on  intracellular  bioactive  fungal  metabolites,  neglected  until  now.  For 
purposes of neuroactivity screening, mycelium seems to be more attractive than medium and, thus, 
should be independently investigated. 
Cytotoxicity was detected in both mycelium and medium extracts from ASF and SmF with no 
marked  differences  (e.g.,  Phoma  sp.)  or  in  either  mycelium  extracts  (Pycnidiophora  dispersa)  or 
medium extracts (Phoma exigua and Scopulariopsis sp.)(Table 2). These observations revealed the 
diversity of cytotoxic compounds in our six studied strains and led us to conclude that mycelium and 
medium should be independently investigated in a cytotoxicity screening context. 
2.4. The proposed strategy  
The objective of this study was to build a rational methodology for the production and extraction of 
hydrophilic bioactive fungal metabolites. The outcome is that fungal production by ASF and extraction 
by an aqueous process using cryo-crushing of mycelium and enzymatic digestion of medium with 
agarase is the best strategy to screen bioactive hydrophilic substances. The resulting general procedure 
is presented in Figure 3.  
Figure  3. Proposed protocol for the production and extraction of bioactive hydrophilic 
fungal metabolites. 
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According to this protocol and to the bioactivity results, some selected crude extracts were purified. 
A process of partial-purification by ammonium sulfate (AS) and trichloroacetic acid (TCA) enabled 
the protein and peptide fractions  to  be  concentrated  (data not  shown). The use of TCA could be 
justified, with regard to the AS action, by its efficiency in precipitating very diluted proteins, as in the 
case of metabolites secreted into the medium [18]. Bioactivities increased with fractionation, proving 
that this technique is suitable for further purifications (data not shown). 
2.5. Marine fungi, a promising source of bioactive hydrophilic substances 
This study highlighted the production of bioactive hydrophilic substances by marine fungi, hitherto 
neglected.  In  fact,  although  only  six  marine  fungal  strains  were  screened  for  the  detection  of 
hydrophilic  neuroactive  and  cytotoxic  metabolites,  several  of  the  obtained  extracts  exhibited 
bioactivities.  Identification  of  the  bioactive  compounds  should  be  investigated.  The  probability  of 
finding some molecules already described is low because no neuroactive hydrophilic substances have 
yet been identified in fungi. However, hydrophilic protein phytotoxins have already been described in 
terrestrial Phoma strains [19–21]. The presence of such toxins in Phoma extracts could explain the 
observed neuroactivity and, thus, need to be investigated. 
Similarly,  no  cytotoxic  hydrophilic  compounds  have  previously  been  reported  for  the  genera 
Pycnidiophora, Scopulariopsis and Phoma. Thus, the activities observed in mycelium extracts of these 
strains could reveal the presence of undescribed hydrophilic compounds. Some cytotoxic hydrophilic 
proteins, such as  ribotoxins [22] and lectins [8,23] have already been described from Aspergillus, 
Fusarium and Rhizoctonia strains. They have more recently been identified in various genera [24,25] 
but have not yet been mentioned in the species studied here.  
This study has demonstrated the production of potentially bioactive fungal metabolites by marine 
strains. These findings confirm the need to investigate marine fungi for their production of hydrophilic 
substances in the search for new natural molecules of pharmaceutical interest.  
3. Experimental Section 
3.1. Fungal strains and culture medium 
All studied strains were isolated from samples collected in shellfish-farming areas of the Loire 
estuary  on  the  French  Atlantic  coast.  Fungal  strains  were  identified  by  sequencing  the  internal 
transcribed spacers (ITS 1 and 2) and beta-tubulin regions of the ribosomal RNA cluster as Penicillium 
citreonigrum, Phoma exigua var exigua, Phoma sp., Scopulariopsis sp., Pycnidiophora dispersa and 
Chrysosporium queenslandicum. All strains were maintained as stock cultures on Dextro Casein Agar 
(DCA) tubes (dextrose 40 g, enzymatic digest of casein 10 g, agar 15 g, natural filtered seawater 1 L), 
stored under a paraffin oil layer and conserved in our fungal collection under the reference numbers 
MMS 029, MMS 719, MMS 797, MMS 850, MMS 940 and MMS 946, respectively (MMS: Marine 
Fungal Collection, University of Nantes). For the current work, the six fungal strains were cultured on 
yeast extract sucrose agar medium (YES) in two types of fermentation: SmF and ASF in the culture 
conditions commonly used in our laboratory (27 ° C, natural light). This medium was chosen for its 
high concentration in sugar and amino acids in order to promote fungal growth, metabolite production Mar. Drugs 2011, 9                       
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and glycosylation mechanisms. Yeast extract medium was composed of 20 g yeast extract, 150 g 
saccharose, 0.5 g MgSO4, 7H2O, 0.01 g ZnSO4, 7H2O and 0.005 g CuSO4, 5H2O dissolved in 1 L of 
natural filtered seawater and was supplemented with 20 g of agar for ASF. 
3.2. Agar surface fermentation: culture and extraction 
3.2.1. Agar surface fermentation 
Agar surface fermentations were performed in Petri dishes (16 cm) containing 80 mL of YES agar 
medium.  Media  were  inoculated  with  fungal  conidia  of  the  six  different  strains  taken  from  stock 
cultures. Each Petri dish was then incubated at 27 °C , under natural light, until the dish surface was 
totally covered by the mycelium, the incubation time corresponding to the required growth time (15 to 
45 days). Mycelia were then separated from  their media by scraping them  from  agar-agar with a 
scalpel. This mechanical separation was selected for its simplicity and its easy application on a large 
quantity of fungal  cultures  at  the laboratory scale. Then mycelia were washed several  times  with 
distilled water and both mycelia and agar-agar were cut into small pieces using a scalpel. 
3.2.2. Extraction of agar-agar  
3.2.2.1 Extraction of agar-agar by aqueous process (EAP)  
A  preliminary  study  had  been  developed  on  artificial  agar-agar  supplemented  with  standards 
(albumins and insulin): a cryo-crushing followed by a water maceration had been compared to an 
enzymatic digestion with agarase at several units. The outcome from this preliminary study was that an 
enzymatic digestion was more efficient and easier to achieve; moreover 10 U of agarase was sufficient 
to liquefy the agar-agar completely in a short time (2 hours).  
Thus, pieces of agar-agar from ASF were suspended in distilled water containing 10 U of agarase 
from Pseudomonas atlantica (Sigma A-6306, USA) solubilized in distilled water and the homogenates 
were stirred at 40 ° C for 2 h (one unit of agarase is expressed as the amount of enzyme producing 1 µg 
of agar per minute at 40 ° C). Once the agar-agar was liquefied, enzymatic digestion was stopped by 
cooling  and  the  agar-agar  residues  were  separated  from  solubilized  compounds  by  centrifugation 
(15,000 g for 30 min, then 20,000 g for 15 min at 4 ° C). Supernatants were collected to constitute 
crude extracts of extracellular hydrophilic fungal metabolites and filtered under vacuum to remove 
spores (0.45 µ m PTFE membrane filters, Sartorius, Germany). As they are undesirable for the effective 
operation of many analyses, salts were removed from crude extracts by dialysis, using cellulose tube 
(MW cut-off 3,500 Da, cellu.sep®, USA) against distilled water under shaking at 4 ° C.  
3.2.2.2. Extraction of agar-agar by organic process (EOP) 
Metabolites contained in pieces of agar-agar were extracted by a shaken methanolic maceration at 
room temperature. Agar-agar residues were eliminated by successive filtrations, and liquid organic 
phases were filtered under vacuum to remove spores (0.45 μm) then evaporated to obtain dry extracts. 
Hydrophobic compounds were removed by a liquid/liquid partitioning using CH2Cl2/H2O (3/1, v/v), Mar. Drugs 2011, 9                       
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and aqueous phases containing the target compounds were kept as the extracellular hydrophilic crude 
extracts. Salts were removed by dialysis as described above.  
3.2.3. Extraction of mycelium  
As  for  agar-agar,  the  hydrophilic  metabolites  contained  in  mycelium  pieces  from  ASF  were 
extracted  by  two  processes:  an  organic  process  (EOP)  consisting  of  a  methanolic  maceration  as 
described  above  and  an  aqueous  process  (EAP)  consisting  of  a  cryo-crushing  followed  by  a  
distilled-water maceration. Concerning the latter, pieces of mycelium were freeze-dried, weighed and 
then ground into powder in liquid nitrogen. Powders were immersed in distilled water at 4 ° C under 
shaking for 2 h. Mycelia extraction residues were removed by a  gauze filtration. Macerates  were 
centrifuged (10,000 g, 20 min, 4 ° C) and supernatants were collected to constitute crude extracts of 
intracellular hydrophilic fungal metabolites. Both supernatants and aqueous phases containing target 
compounds were kept as the hydrophilic mycelium crude extracts. Crude extracts were finally filtered 
under vacuum to remove spores (0.45 µ m) and then dialysed as described above.  
Concerning the extraction of mycelium by an aqueous process, an enzymatic digestion could not  
be  considered  because  fungal  walls  are  species-dependent,  with  a  high  level  of  complexity  and 
variability [26]. Thus, cryo-crushing was the only technique used.  
3.3. Submerged fermentation: culture and extraction 
3.3.1. Submerged fermentation 
Submerged  fermentations  were  performed  in  500  mL  Erlenmeyer  flasks  with  250  mL  of  YES 
medium. A suspension of 0.5 ×  10
6 spores/mL was prepared from ASF and inoculated. Cultures were 
then incubated at 27 ° C under natural light (25 to 50 days). A paper filtration under vacuum separated 
the mycelia from the culture media. Then mycelia were washed several times with distilled water and 
cut into small pieces using a scalpel. 
3.3.2. Extraction from SmF 
Only  one  extraction  process,  EAP,  was  applied  on  mycelia  from  SmF.  Mycelium  pieces  were  
cryo-crushed in liquid nitrogen and macerated in water as described above for mycelia from ASF. Both 
culture filtrates and mycelium macerates were centrifuged (10,000 g, 20 min, 4 ° C). Supernatants were 
collected to constitute crude extracts of intracellular and extracellular hydrophilic fungal metabolites. 
Finally, crude extracts were filtered under vacuum to remove spores (0.45 µm) and dialysed.  
3.4. Biochemical and bioactivity evaluations 
3.4.1. Characterization and measurement  
Total protein contents of extracts were determined according to the Bradford method [27] with 
bovine serum albumin as a standard. Characterization of proteins was performed by sodium dodecyl 
sulfate polyacrylamide gel  electrophoresis according to the method of Laemmli [28] using a 12% 
resolving  gel,  a 5% stacking  gel  and Precision Plus  Protein  from  Bio-Rad as  a molecular  weight Mar. Drugs 2011, 9                       
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marker. Proteins and peptides were stained with Coomassie blue (Coomassie Brilliant Blue 5R 250, 
Sigma), periodic acid Schiff (Sigma-Aldrich) and silver nitrate (Silver Stain Plus, Bio-Rad).  
Total  sugars  were  estimated  using  the  colorimetric  phenol-sulfuric  acid  method  [29]  with  
L-glucose as a standard, and expressed as mg of glucose per g of dried weight. In brief, 1 mL of sample 
solution was vortexed with 1 mL of 5% phenol in water before adding 5 mL of concentrated sulfuric 
acid rapidly from a glass dispenser. After standing for 30 min at room temperature, the absorbance of 
the sample solution was measured at 485 nm against a blank. In addition, estimations of proteins and 
sugars were made on inert YES solid and liquid media extracted like those from fungal fermentations.  
3.4.2. Bioactivity assays  
3.4.2.1. Neuroactivity assay on blowfly larvae  
The neuroactivity of extracts was evaluated following the method described by Zoltkin [30]. All 
assays were performed with larvae of the blue fly Calliphora vomitoria which were at the last stage 
before pupariation. The larvae were obtained from fishing supply stores. Extracts to be tested were 
dissolved in distilled water at an initial concentration of 100 mg/mL. Test solutions were injected 
(0.1 μL per mg of larval body) using a 10 μL micro-syringe with a thin hypodermic needle (Hamilton, 
Bonaduz, Switzerland). The needle was inserted into the ventral side at the level of the last abdominal 
segment and extract was slowly injected. The time (T) required for immobilization of the larvae after 
injection was measured. If no immobilization occurred after 10 min, the test was considered negative. 
Three replicates were tested for each dose and the median value was calculated. If a positive response 
was observed at the initial tested concentration, a range of dilutions was prepared and tested. The 
Minimal Effective Dose (MED) is defined as the lowest concentration producing an immobilization of 
larvae.  A  crude  extract  was  considered  interesting  if  it  exhibited  a  maximal  MED  of  25 mg/mL 
(internal  criteria  according  to  our  own  experiments).  Domoic  acid  (0.125  mg/mL)  was  used  as  a 
positive control [31] and distilled water as a negative control. 
3.4.2.2. Cytotoxicity assay 
The epidermoid human carcinoma KB cells (ATCC CCL 17, Rockville, MD) were maintained at  
37 ° C in 5% CO2 with Eagle’s basal medium (BME) supplemented with 10% (v/v) fetal calf serum, 
1%  (v/v)  glutamine  200  mM  and  1%  (v/v)  streptomycin/penicillin  10  mg/mL.  50  µL  of  a  
2 ×  10
5 cell/mL suspension was placed in wells of 96-well culture plates and incubated for 48 h. Serial 
dilutions  of  extracts  in  BME  were  added  (initial  concentration:  250  µg/mL).  Microplates  were 
incubated  for  72  h.  Then  3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium  bromide  (MTT, 
purchased from Sigma-Aldrich, 5 mg/mL in distilled water) was added. After 2 h of incubation, dyed 
formazan crystals were dissolved in isopropanol 0.04% HCl 1N and absorbance values were measured 
at 570 nm and 630 nm (background noises) using a scanning multi-well spectrophotometer [32]. All 
assays were performed in triplicate. Semi-logarithmic plots were constructed from the averaged data, 
and the effective doses of extracts required to inhibit cell growth by 50% (IC50) were determined. 
Gliotoxin (1 µg/mL) was used as a positive control and BME as a negative control. Mar. Drugs 2011, 9                       
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Values of IC50 of crude extracts were chosen according to the NCI screening program: extracts of 
IC50 > 30 µg/mL can be considered inactive; extracts of 10 < IC50 < 30µg/mL are weakly active, 
extracts with IC50 < 10 µ g/mL are highly active [12]. 
4. Conclusion 
A methodology for the production and extraction of bioactive hydrophilic fungal metabolites has 
been  developed.  Our  model  consists  of  fungal  production  by  ASF  and  extraction  by  an  aqueous 
process  using  cryo-crushing  of  mycelium  and  enzymatic  digestion  of  medium  by  agarase.  These 
results can be improved by evaluating different compositions of medium. The model proposed in this 
study will be implemented in our lab, and its application on strains from our marine fungal collection 
will complete the well-established screening of hydrophobic bioactive metabolites and improve the 
efficiency  of  the  search  for  bioactive  fungal  metabolites  by  screening  them  over  all  their  
polarity range. 
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